untitled design

Finally the AstraZeneca vaccines for the European Union – What will happen to the second doses of those who have been vaccinated

No order from the European Union for its vaccines has been renewed AstraZeneca against coronavirus for the period after the beginning of June.

This was stated by the European Commissioner for the Internal Market, Thierry Breton, according to what APE-MPE reports on Sunday 9/5.

THE Commission last month took legal action against AstraZeneca for non-compliance with its contract regarding the delivery of its COVID-19 vaccines, but also for the absence of a “credible” plan from the company, to ensure timely delivery of vaccines.

However, according to the Ministry of Health and the National Vaccination Committee, there should be no concern for those who have already made the first dose of the vaccine as for these citizens the 2nd has already been secured.

The President of France, Emanuel Macron, greet her EU decision not to order new coronavirus vaccines from AstraZeneca.

Answering a question at the European Parliament in Strasbourg, the French President spoke positively of the decision, as he considered some other vaccines to be more effective against the new variants of Covid-19.

“We are currently vaccinating with this vaccine (AstraZeneca) in France and Europe. “We have to keep doing this, because it will help us get out of the crisis,” Macron said.

“But for future orders, in order to specifically respond to variants of the virus, we see that other vaccines are now more effective, so that signals a European realism that I welcome,” he added.

The EMA is evaluating reports of its appearance after the AstraZeneca vaccine

The European Medicines Agency (EMA) said on Friday it was reviewing reports of a rare disease affecting the nerves after being vaccinated with AstraZeneca and asked the pharmaceutical industry for more information.

As part of the planned evaluations of Vaxzevria vaccine safety issues, the Coreper Safety Committee analyzes data from Guillain-Barre syndrome.

According to Reuters, AstraZeneca did not immediately respond to requests for comment.

What is Guillain-Barre Syndrome that causes paralysis?

According to statements made last February by Theodoros Vasilakopoulos, Professor of Pulmonology – Intensive Care at the Medical School of the University of Athens, «The syndrome starts with peripheral paralysis but can also go up and paralyze the respiratory muscles and require a ventilator.

This of course concerns rare cases. It is common for this syndrome to be fully restored with proper treatment. “

You may also like

Consensys sues the SEC
Top News
David

Consensys sues the SEC

Consensys, the developer of the MetaMask wallet, has filed a lawsuit against the US Securities and Exchange Commission (SEC). The

Get the latest

Stay Informed: Get the Latest Updates and Insights

 

Most popular